Orthofix Medical (OFIX) Gross Margin (2010 - 2026)

Orthofix Medical (OFIX) recorded quarterly Gross Margin of 74.98% in Q1 2026, up 5.46% on a QoQ basis from 71.09% in Q4 2025, and up 802.0% year-over-year from 8.31% in Q1 2025.

Orthofix Medical (OFIX) Gross Margin (2010 - 2026) Analysis & Trends

Orthofix Medical has disclosed Gross Margin across 17 years of filings, most recently posting 74.98% for Q1 2026.

  • Quarterly Gross Margin rose 802.0% year-over-year to 74.98% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 73.8% (up 87.0% YoY) and the FY2025 annual result came in at 68.83%, down 417.0% from the prior year.
  • Gross Margin climbed to 74.98% in Q1 2026, from 71.09% in the prior quarter.
  • Over five years, Gross Margin peaked at 133.19% in Q4 2022 and troughed at 65.09% in Q3 2023.
  • A 5-year average of 78.3% and a median of 72.9% in 2025 frame the typical range for Gross Margin.
  • Annual changes were most pronounced in 2022 — Gross Margin surged 4999 bps — and 2023, when it slumped 4032 bps.
  • Tracing OFIX's Gross Margin over 5 years: stood at 133.19% in 2022, then sank by 30 bps to 92.87% in 2023, then retreated by 2 bps to 90.78% in 2024, then fell by 22 bps to 71.09% in 2025, then advanced by 5 bps to 74.98% in 2026.
  • Business Quant data shows OFIX's Gross Margin at 74.98% in Q1 2026, 71.09% in Q4 2025, and 76.63% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 56.20%
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 63.29%
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 63.83%
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 69.46%
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 78.01%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 45.22%
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 62.95%
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 38.53%
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 43.89%
10 Orthofix Medical 382.66 Mn 261.79 Mn 139.55 Mn 74.98%

Historic Data

Download Data
DateValue
Mar 31, 2026 74.98%
Dec 31, 2025 71.09%
Sep 30, 2025 76.63%
Jun 30, 2025 72.90%
Mar 31, 2025 66.96%
Dec 31, 2024 90.78%
Sep 30, 2024 68.69%
Jun 30, 2024 67.84%
Mar 31, 2024 72.37%
Dec 31, 2023 92.87%
Sep 30, 2023 65.09%
Jun 30, 2023 68.68%
Mar 31, 2023 68.00%
Dec 31, 2022 133.19%
Sep 30, 2022 73.18%
Jun 30, 2022 83.50%
Mar 31, 2022 84.33%
Dec 31, 2021 83.21%
Sep 30, 2021 74.82%
Jun 30, 2021 77.40%